Lataa...
Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations
Pancreatic cancer is the third leading cause of cancer mortality in both men and women in the United States, with poor response to current standard of care, short progression-free and overall survival. Immunotherapies that target cytotoxic T lymphocyte antigen-4, programmed cell death protein-1, and...
Tallennettuna:
| Julkaisussa: | World J Clin Oncol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Inc
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5465012/ https://ncbi.nlm.nih.gov/pubmed/28638792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v8.i3.230 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|